Struggling Microchip Technology announced it has brought in Macquarie Group to facilitate the sale of its manufacturing facility in Tempe, Ariz., and that it has launched a $1.35 billion convertible stock offering.
(Bloomberg) -- Argentina is waiting for yields on its sovereign bonds to edge below 10% before exploring a long-awaited return to international capital markets, a government official told investors in a presentation in Buenos Aires.Most Read from BloombergNew York Subway Ditches MetroCard After 32 Years for Tap-And-GoAmtrak CEO Departs Amid Threats of a Transit Funding PullbackDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleLA Faces $1 Billion Budget Hole, Warns of Thousands of
Microsoft initiated, Rivian downgraded: Wall Street's top analyst calls
(Bloomberg) -- Kraken is acquiring retail futures trading platform NinjaTrader for $1.5 billion, allowing the crypto exchange to offer crypto futures and derivatives in the US for the first time and to expand into more traditional markets. Most Read from BloombergNew York Subway Ditches MetroCard After 32 Years for Tap-And-GoAmtrak CEO Departs Amid Threats of a Transit Funding PullbackDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleLA Faces $1 Billion Budget Hole, Warns of Thous
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 8.4%. This drop was disappointing since the S&P 500 stood firm.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 8.4%. This drop was disappointing since the S&P 500 stood firm.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.